J Bladé
About
In The Last Decade
J Bladé
14 papers receiving 164 citations
Peers
Comparison fields: 5 of 42
- Oncology 112
- Hematology 66
- Orthopedics and Sports Medicine 56
- Molecular Biology 38
- Rheumatology 24
Countries citing papers authored by J Bladé
This map shows the geographic impact of J Bladé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Bladé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Bladé more than expected).
Fields of papers citing papers by J Bladé
This network shows the impact of papers produced by J Bladé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Bladé. The network helps show where J Bladé may publish in the future.
Co-authorship network of co-authors of J Bladé
This figure shows the co-authorship network connecting the top 25 collaborators of J Bladé. A scholar is included among the top collaborators of J Bladé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Bladé. J Bladé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates. | 78 |
| 4 | [Hyperviscosity syndrome and mental disorders]. | 2 |
| 5 | [Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona]. | 3 |
| 6 | Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma. | 46 |
| 7 | [IgM myeloma: a report of 2 cases]. | 1 |
| 8 | 15 | |
| 9 | Infecciones en el paciente inmunodeprimido | 0 |
| 10 | [Multiple myeloma and idiopathic monoclonal gammapathy. Diagnosis, prognosis and treatment]. | 2 |
| 11 | Treatment of blast crisis of chronic myelogenous leukemia with vincristine, prednisone, and cytarabine. | 8 |
| 12 | [Multiple myeloma: description of a series of 170 cases]. | 1 |
| 13 | [Idiopathic myelofibrosis with cutaneous myeloid metaplasia]. | 2 |
| 14 | 7 | |
| 15 | [Early thrombosis of the central retinal artery and oral contraceptives]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.